| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2019-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cee1fdf2372e5c6e091e046a3238b91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fde6bdb2b2715c7d3ae1ffb432eb7bfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42292a8f1597ff94fd23ab115d5f5b86 |
| publicationDate |
2019-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190137724-A |
| titleOfInvention |
Composition for treating norovirus infecton |
| abstract |
The present invention relates to a composition for treating norovirus, and more particularly, the present invention does not upregulate expression of TLR4 through oral administration of gamma-PGA, and does not induce the production of inflammatory cytokines without inducing IFN-beta. It can be used as an antiviral agent against norovirus by inducing the production of. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210087899-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102263733-B1 |
| priorityDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |